Campus Vienna Biocenter 2
1030 Vienna, at
+43 (1) 20620-303
Changes to the Supervisory Board
Michel Gréco is serving as chairman or board member in a variety of supervisory boards of renowned companies and nonprofit organizations which are devoted to the development and commercialization of vaccines. Previously, Mr. Gréco was Deputy Chief Executive Officer of Aventis Pasteur S.A., now Sanofi Pasteur S.A.
Helmut Schühsler, who represented the private equity firm TVM Capital on Intercell's Supervisory Board, resigns from his position. The company would like to thank Helmut Schühsler, who has been a member of the supervisory board for more than seven years, for his long-term commitment to the company and his outstanding support of Intercell on its way from a university spin-off to an internationally acknowledged vaccine player in the biotech arena. The Supervisory Board of Intercell now includes the following members: Michel Gréco (Chairman), Ernst-Günter Afting (Vice-chairman), Staph Bakali, David Ebsworth, Hans Küpper, James Sulat and Hans Wigzell.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.